Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Sex differences and serotonergic mechanisms in the behavioural effects of psilocin

Tylš Filip, Páleníček Tomáš, Kadeřábek Lukáš, Lipski Michaela, Kubešová Anna, Horáček Jiří

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (83)

  1. Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake Rats 2015-01-01 · Expand citations
  2. Hallucinogenic drugs in pre-Columbian Mesoamerican cultures. 2015-01-01 · Expand citations
  3. The Effect of Psilocin on Memory Acquisition, Retrieval, and Consolidation in the Rat 2014-05-16 · Expand citations
  4. Psilocybin--summary of knowledge and new perspectives. 2014-03-01 · Expand citations
  5. Serotonergic hallucinogens as translational models relevant to schizophrenia. 2013-11-01 · Expand citations
  6. Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. 2012-02-01 · Expand citations
  7. Prediction of psilocybin response in healthy volunteers. 2012-01-01 · Expand citations
  8. Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice. 2011-11-01 · Expand citations
  9. Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. 2011-09-01 · Expand citations
  10. Serotonin research: contributions to understanding psychoses. 2008-09-01 · Expand citations
  11. Psilocybin-induced stimulus control in the rat. 2007-10-01 · Expand citations
  12. Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys. 2004-03-01 · Expand citations
  13. Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines. 2000-11-30 · Expand citations
  14. 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride. 1999-05-01 · Expand citations
  15. A characteristic effect of hallucinogens on investigatory responding in rats. 1979-09-01 · Expand citations
  16. Psilocybin: biphasic dose-response effects on the acoustic startle reflex in the rat. 1977-04-01 · Expand citations
  17. Behavioural Effects of some Morphine Antagonists and Hallucinogens in the Rat 1968-10-31 · Expand citations
  18. Psilocin: effects on behaviour and brain serotonin in mice. 1966-02-19 · Expand citations
  19. 10.1002/da.10089
  20. 10.1002/ddr.430040602
  21. 10.1007/bf00407977
  22. 10.1007/bf02245096
  23. 10.1007/s00213-006-0566-1
  24. 10.1007/s00213-007-0926-5
  25. 10.1007/s00213-009-1718-x
  26. 10.1007/s00213-012-2797-7
  27. 10.1007/s002130100811
  28. 10.1016/0024-3205(67)90124-5
  29. 10.1016/0024-3205(71)90232-3
  30. 10.1016/0091-3057(86)90477-6
  31. 10.1016/0091-3057(91)90104-a
  32. 10.1016/0277-9536(95)00045-9
  33. 10.1016/0301-0082(94)90057-4
  34. 10.1016/0960-0760(95)00075-b
  35. 10.1016/j.bbr.2011.01.026
  36. 10.1016/j.bcp.2007.07.018
  37. 10.1016/j.beproc.2008.02.019
  38. 10.1016/j.biopsych.2007.03.001
  39. 10.1016/j.bmc.2009.03.021
  40. 10.1016/j.brainres.2005.08.051
  41. 10.1016/j.brainres.2011.04.039
  42. 10.1016/j.neubiorev.2014.03.001
  43. 10.1016/j.neulet.2007.02.039
  44. 10.1016/j.pbb.2012.12.004
  45. 10.1016/j.pharmthera.2003.11.002
  46. 10.1016/j.physbeh.2003.07.012
  47. 10.1016/j.physbeh.2005.08.043
  48. 10.1016/j.pnpbp.2010.02.008
  49. 10.1016/s0006-3223(98)00162-0
  50. 10.1016/s0006-8993(97)00136-4
  51. 10.1016/s0014-2999(96)00621-8
  52. 10.1016/s0022-3565(24)34994-8
  53. 10.1016/s0022-3565(25)10375-3
  54. 10.1016/s0022-3565(25)20660-7
  55. 10.1016/s0028-3908(97)00038-5
  56. 10.1016/s0028-3908(97)00042-7
  57. 10.1016/s0028-3908(99)00010-6
  58. 10.1016/s0091-3057(01)00552-4
  59. 10.1016/s0091-3057(97)00391-2
  60. 10.1016/s0091-3057(99)00091-x
  61. 10.1016/s0166-4328(00)00345-4
  62. 10.1016/s0169-328x(02)00134-1
  63. 10.1016/s0169-328x(98)00148-x
  64. 10.1016/s0169-328x(98)00295-2
  65. 10.1016/s0169-328x(99)00274-0
  66. 10.1016/s0304-3940(01)02570-8
  67. 10.1016/s0893-133x(00)00085-3
  68. 10.1016/s0893-133x(01)00282-2
  69. 10.1016/s0893-133x(01)00345-1
  70. 10.1017/s1092852912001010
  71. 10.1038/npp.2009.29
  72. 10.1038/sj.bjp.0702350
  73. 10.1038/sj.bjp.0705887
  74. 10.1046/j.1471-4159.2000.740693.x
  75. 10.1097/00008877-199512000-00010
  76. 10.1097/00008877-200503000-00009
  77. 10.1111/j.1476-5381.1973.tb08274.x
  78. 10.1111/j.1476-5381.1996.tb15304.x
  79. 10.1111/j.1600-0773.1995.tb00122.x
  80. 10.1124/jpet.106.106989
  81. 10.1371/journal.pone.0009019
  82. 10.1590/s1519-69842002000400008
  83. 10.3181/00379727-105-26073

Cited by — these papers cite this paper (9)

  1. Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats 2026-10-01 · Expand citations
  2. Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping review 2026-03-09 · Expand citations
  3. Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse Prevention 2026-03-01 · Expand citations
  4. Cross-Species Evidence for Psilocin-Induced Visual Distortions: Apparent Motion Is Perceived by Both Humans and Rats 2025-09-01 · Expand citations
  5. Extraction Yields of Psilocybin and Psilocin: A Short Review of Current Methods and Their Implications 2025-03-07 · Expand citations
  6. Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats 2023-06-22 · Expand citations
  7. Psilocin, LSD, mescaline, and DOB all induce broadband desynchronization of EEG and disconnection in rats with robust translational validity 2021-10-02 · Expand citations
  8. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels 2019-06-01 · Expand citations
  9. Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats 2018-09-01 · Expand citations